Integrative Medicine in Nephrology and Andrology

EDITORIAL
Year
: 2022  |  Volume : 9  |  Issue : 1  |  Page : 3-

Applying the guidelines to standardize the behavior of clinicians in the treatment of chronic kidney disease with Chinese patent medicine


Qingli Cheng1, Ping Li2 
1 Department of Nephrology, The Second Medical Center of Chinese PLA General Hospital, National Clinical Research Centre for Geriatric Diseases, Beijing, China
2 Beijing Key Laboratory for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China

Correspondence Address:
Dr. Ping Li
Beijing Key Laboratory for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029
China




How to cite this article:
Cheng Q, Li P. Applying the guidelines to standardize the behavior of clinicians in the treatment of chronic kidney disease with Chinese patent medicine.Integr Med Nephrol Androl 2022;9:3-3


How to cite this URL:
Cheng Q, Li P. Applying the guidelines to standardize the behavior of clinicians in the treatment of chronic kidney disease with Chinese patent medicine. Integr Med Nephrol Androl [serial online] 2022 [cited 2022 Oct 7 ];9:3-3
Available from: https://journal-imna.com//article.asp?issn=2773-0387;year=2022;volume=9;issue=1;spage=3;epage=3;aulast=Cheng;type=0